What are the Challenges in Targeting Oncogenic RNAs?
There are several challenges in targeting oncogenic RNAs for therapy. One major challenge is the delivery of therapeutic molecules to the target tissues and cells. [RNA molecules](https://) are inherently unstable and can be degraded by nucleases in the bloodstream. Moreover, off-target effects and immune responses are potential obstacles that need to be addressed. Researchers are developing advanced delivery systems, such as lipid nanoparticles and viral vectors, to overcome these challenges.
